Bystander Activation and Anti-Tumor Effects of CD8+ T Cells Following Interleukin-2 Based Immunotherapy Is Independent of CD4+ T Cell Help

We have previously demonstrated that immunotherapy combining agonistic anti-CD40 and IL-2 (IT) results in synergistic anti-tumor effects. IT induces expansion of highly cytolytic, antigen-independent “bystander-activated” (CD8(+)CD44(high)) T cells displaying a CD25(−)NKG2D(+) phenotype in a cytokin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Monjazeb, Arta M., Tietze, Julia K., Grossenbacher, Steven K., Hsiao, Hui-Hua, Zamora, Anthony E., Mirsoian, Annie, Koehn, Brent, Blazar, Bruce R., Weiss, Jonathan M., Wiltrout, Robert H., Sckisel, Gail D., Murphy, William J.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4131875/
https://ncbi.nlm.nih.gov/pubmed/25119341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0102709
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados